Personalized Immune Cell Treatment
Meet the blockchain structure of NKCL Classic, where biotechnology and blockchain technology are perfectly combined
NK cells play a major role in our immune system
Explore NKCL Classic Project
1. Brief introduction of your
company and current status please.
Hello. This is Shin, Dong-Hwa, the
Chairman of NKCL Bio Group◆ Please
give us a brief introduction of yourself.
NKCL Bio Group Inc., a
company specialized in NK cell culture technology, participated in the 1st
The 2022 Virus and Bacteria Trend Conference will be held, where domestic bacteria and virus-related companies ..
NKCL Bio Group Inc. (NKCL) has announced that it had signed a 3-party MOU with PnB Group and MK Lab for distrib..
On July 4, NKCL Bio Group Inc. (CEO Shin, Donghwa) and I Partners Group (CEO Jung, Yiho) announced that they ha..
chairman of NKCL Bio Group Inc.(NKCL Bio Group), was honored with the Grand Prize
in the NK ce..
On June 28, the 'JTC Group of Companies ' visited NKCL Bio Group.NKCL Biogroup has explained its technological ..
On the 20th,
the Cambodian economic delegation, the Reachsey Association, visiting Korea at
the moment, visit..
NKCL Bio Group
Inc. (Chairman Dong-Hwa Shin, hereinafter referred to as NKCL) announced that
it had acquired ..
소중한 정보를 남겨주시면 상담을 위한 신속한 연락 드리겠습니다.